Compare
Krystal Biotech, Inc. vs Immunocore Holdings plc vs Tarsus Pharmaceuticals, Inc. vs Twist Bioscience Corp
| Latest fiscal year | Krystal Biotech, Inc. KRYS | Immunocore Holdings plc IMCR | Tarsus Pharmaceuticals, Inc. TARS | Twist Bioscience Corp TWST |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2026-09-30 |
| Revenue | $389.13M | $400.02M | $451.36M | $459.43M |
| Revenue growth (YoY) | +33.9% | +29.0% | +146.7% | +22.0% |
| Gross margin | n/a | n/a | n/a | 52.4% (computed) |
| Operating margin | 41.5% | -11.3% | -15.7% | -30.4% |
| Net margin | 52.6% | -8.9% | -14.7% | -28.3% |
| Net income | $204.83M | -$35.51M | -$66.42M | -$130.20M |
| EPS (Diluted) | $6.84 | -$0.71 | -$1.59 | -$2.08 |
| Operating cash flow | $200.87M | -$10.71M | -$12.45M | -$41.43M |
| Free cash flow | $188.91M | -$15.05M | -$22.31M | -$89.01M |
| Cash & equivalents | $496.30M | $467.71M | $183.64M | $533.99M |
| Total assets | $1.33B | $1.07B | $562.16M | $1.12B |
| Total liabilities | $114.23M | $686.24M | $218.73M | $233.79M |
| Shareholders' equity | $1.22B | $381.03M | $343.43M | $888.02M |
| Return on year-end equity | 16.8% | -9.3% | -19.3% | -14.7% |
| Shares outstanding | 29.19M | 50.69M | 42.55M | 67.81M |
Revenue, most recent five fiscal years
| Fiscal year | Krystal Biotech, Inc. | Immunocore Holdings plc | Tarsus Pharmaceuticals, Inc. | Twist Bioscience Corp |
|---|---|---|---|---|
| Latest | $389.13M Ended 2025-12-31 | $400.02M Ended 2025-12-31 | $451.36M Ended 2025-12-31 | $459.43M Ended 2026-09-30 |
| 1 year earlier | $290.51M Ended 2024-12-31 | $310.20M Ended 2024-12-31 | $182.95M Ended 2024-12-31 | $376.57M Ended 2025-09-30 |
| 2 years earlier | $50.70M Ended 2023-12-31 | $249.43M Ended 2023-12-31 | $17.45M Ended 2023-12-31 | $312.97M Ended 2024-09-30 |
| 3 years earlier | $0 Ended 2022-12-31 | $174.36M Ended 2022-12-31 | $25.82M Ended 2022-12-31 | $245.11M Ended 2023-09-30 |
| 4 years earlier | $0 Ended 2021-12-31 | $36.48M Ended 2021-12-31 | $57.03M Ended 2021-12-31 | $203.56M Ended 2022-09-30 |